OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for October, 2011

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2011-10-31 00:00 Dividend Yield Vs. Dividend Growth: Are You Better Off With Eli Lilly Or Procter & Gamble? and more... 2011-10-30 00:00 Ajanta Pharma Continues Growth and more... 2011-10-29 00:00 Biogen profits up 38 percent and more... 2011-10-28 00:00 Regeneron 3Q loss widens as expenses climb and more... 2011-10-27 12:00 Bristol-Myers Tops Third-Quarter Profit Estimate 2011-10-27 00:00 Another Round Of Milestone News Solidifies Ampio's Pipeline Potential and more... 2011-10-26 00:00 FTC pay-for-delay study flawed? and more... 2011-10-25 12:00 Amgen Third-Quarter Profit Beats Estimates on Higher Sales of Cancer Drugs and more... 2011-10-25 00:00 Sanofi names Meeker CEO of Genzyme and more... 2011-10-24 00:00 China Biotech Week In Review: SFDA Releases 2010 Approval Data and more... 2011-10-23 00:00 Mylan's Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist Patents and more... 2011-10-22 00:00 Abbott Cholesterol Drug Sales Slip After Study and more... 2011-10-21 00:00 Pfizer Settles Detrol Whistle-Blower Suit and more... 2011-10-20 00:00 Jazz Pharma's stock plunges, following FDA warning and more... 2011-10-19 12:00 Dated Information Causes Human Genome To Pop 2011-10-19 00:00 Bristol-Myers, Sanofi $442 Million Plavix Award Upheld on Appeal and more... 2011-10-18 12:00 6 Biotech Stocks With A History Of Earnings Surprises and more... 2011-10-18 00:00 The 8 Highest Potential Returns in Biotechnology and more... 2011-10-17 12:00 Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning and more... 2011-10-17 00:00 FDA skeptical of Teva's Azilect to slow Parkinson's and more... 2011-10-16 00:00 Par Pharma Files Suit Against FDA Rule, Citing 1st Amendment and more... 2011-10-15 00:00 Abbott Laboratories Earnings Preview and more... 2011-10-14 00:00 Several Upcoming Catalysts In Play For Halozyme Therapeutics and more... 2011-10-13 00:00 FDA green lights improved inhaler for Boehringer COPD drug and more... 2011-10-12 12:00 Pfizer Tries to Block Merck Lipitor-Zetia Pill and more... 2011-10-12 00:00 Seattle Genetics: Weighing Bearish And Bullish Opinions and more... 2011-10-11 12:00 Teva, Baxter, Mckesson to Pay $162 Million Punitive Damages Over Propofol and more... 2011-10-11 00:00 3 Companies Leading The Stem Cell Revolution and more... 2011-10-10 00:00 Inhibitex: Recent Price Action Sees Pressure To Cover Mounting and more... 2011-10-09 12:00 Suit accuses pharma companies of Medicaid price-data manipulation 2011-10-09 00:00 BioAdvanceâÔö£é?öé??Ôö£é?ö?ñós ROI tops $11 million and more... 2011-10-08 00:00 FDA approves first diabetes-cholesterol combo pill, Juvisync and more... 2011-10-07 00:00 Dendreon's Earnings Announcement Has Investors Looking For A Sectorwide Turnaround and more... 2011-10-06 00:00 Biotech's Burning Questions for Q3 Earnings and more... 2011-10-05 00:00 Transcept Pharmaceuticals Rises on Potential Sleeping Pill Approval and more... 2011-10-04 00:00 8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers and more... 2011-10-03 00:00 Teva Broadens Platform In Japan's Growing Generics Market and more... 2011-10-02 00:00 Biogen, Teva, Other Drug Makers Face Stock Catalysts in October and more... 2011-10-01 00:00 FDA Biosimilar Guidelines Complete, Awaiting Publication and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe